Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis is a research paper published in PLoS Medicine (2024). On theSindex it has a DataRank of 0.501. It has been cited 15 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.0855
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
National Institute of Allergy and Infectious Diseases
Grant: T32 AI007433
National Institute of Allergy and Infectious Diseases
Grant: R01 AI146555
National Institutes of Health
Grant: 2T32AI007433-11
Program For AIDS CLINICAL RESEARCH TRAINING (PACRT)
National Institutes of Health
Grant: 5R01AI146555-03
Optimal targeting for individual and population-level TB prevention
NCATS NIH HHS
Grant: UL1 TR001863
FWCI
4.78
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals